Annual report pursuant to Section 13 and 15(d)

Note 14 - Income Taxes (Details Textual)

v3.24.4
Note 14 - Income Taxes (Details Textual) - USD ($)
 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2022
Deferred Tax Assets, Valuation Allowance $ 72,502,102 $ 65,135,088  
Unrecognized Tax Benefits   0 $ 0
Domestic Tax Jurisdiction [Member]      
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 7,300,000    
Deferred Tax Assets, Valuation Allowance 69,000,000 61,700,000  
Operating Loss Carryforwards $ 164,200,000    
Open Tax Year 2005 2006 2007 2015 2016 2017 2018 2019 2022 2023    
Domestic Tax Jurisdiction [Member] | Tax Year, 2024 to 2043 Expirations [Member]      
Operating Loss Carryforwards $ 28,600,000    
Domestic Tax Jurisdiction [Member] | Tax Year, Not Subject to Expiration [Member]      
Operating Loss Carryforwards 135,600,000    
Domestic Tax Jurisdiction [Member] | Tax Year, 2038 to 2043 Expirations [Member]      
Tax Credit Carryforward, Amount $ 7,600,000    
Foreign Tax Jurisdiction [Member] | MALAYSIA      
Open Tax Year 2019 2020 2021 2022 2023    
Foreign Tax Jurisdiction [Member] | UNITED KINGDOM      
Open Tax Year 2023    
Foreign Tax Jurisdiction [Member] | Tax Year, Not Subject to Expiration [Member]      
Operating Loss Carryforwards $ 61,200,000    
Foreign Tax Jurisdiction [Member] | Female Health Company (UK) plc [Member]      
Deferred Tax Assets, Valuation Allowance 0 0  
Foreign Tax Jurisdiction [Member] | Veru Biopharma UK Limited [Member]      
Deferred Tax Assets, Valuation Allowance 400,000 300,000  
Foreign Tax Jurisdiction [Member] | Subsidiary, Female Health Company Limited [Member]      
Deferred Tax Assets, Valuation Allowance 3,200,000 $ 3,200,000  
State and Local Jurisdiction [Member]      
Operating Loss Carryforwards 70,000,000    
State and Local Jurisdiction [Member] | Tax Year, 2024 to 2043 Expirations [Member]      
Operating Loss Carryforwards 35,600,000    
State and Local Jurisdiction [Member] | Tax Year, Not Subject to Expiration [Member]      
Operating Loss Carryforwards $ 34,400,000